Newsroom

Arizona Attorney General Tom Horne Files Lawsuit Against GM for Ignition Switch Defects

Nov. 20, 2014

Hagens Berman is pleased to be assisting the Arizona Attorney General in its law enforcement action versus GM that was filed on November 20, 2014. More »

Hagens Berman’s Steve Berman Responds to Takata and Honda Hearing Regarding Airbag Defect Affecting Millions of Vehicles

Nov. 20, 2014

Attorneys from national consumer-rights law firm Hagens Berman representing plaintiffs in the proposed class-action case against Takata and Honda Motor Co. today responded to a testimony delivered by Takata Senior Vice President, Hiroshi Shimizu and Honda Executive Vice President, Rick Schostek on November 20, 2014 to a Senate committee hearing titled “Examining Takata Airbag Defects and the Vehicle Recall Process,” regarding the airbag safety defect affecting millions of vehicles and linked to at least five fatalities. More »

Hagens Berman Alerts Investors of Lead Plaintiff Deadline in Class Action Lawsuit Filed Against Rayonier, Inc. (NYSE: RYN)

Nov. 18, 2014

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors that a class action lawsuit has been filed against Rayonier, Inc. (NYSE: RYN) (“Rayonier” or “the Company). The suit is pending in U.S. District Court for the Southern District of New York, and investors have until January 12, 2015 to move for lead plaintiff. More »

Hagens Berman Reminds Investors of the Upcoming Lead Plaintiff Deadline in the Class Action Lawsuit Against GT Advanced Technologies, Inc. (NASDAQ GS: GTAT)

Nov. 18, 2014

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors that a class action lawsuit has been filed against GT Advanced Technologies Inc. ( More »

Hagens Berman Reminds Investors of Upcoming Lead Plaintiff Deadline of December 26, 2014 in the Lawsuit Against CBD Energy Limited (NASDAQ CM: CBDE)

Nov. 17, 2014

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors that a class action lawsuit has been filed against CBD Energy Limited (NASDAQ CM: CBDE) (“CBDE” or “the Company)—an Australian small cap company with principal offices in London and New York. More »

Judge Adopts 18 Thought Inc. Claim Constructions in Patent Suit against Oracle

Nov. 13, 2014

In a recently filed order, a Northern District of California Judge overwhelmingly agreed with Hagens Berman’s client Thought Inc., adopting Thought’s requested claim constructions and rejecting Oracle’s validity challenges for 17 out of 18 disputed patent claim terms. More »

Nationally Recognized Patent and Intellectual Property Attorney Joins Hagens Berman Sobol Shapiro

Nov. 12, 2014

Philip Graves, a nationally recognized patent and intellectual property litigation attorney, announced today that he has joined the Los Angeles office of the class-action and large-scale litigation firm Hagens Berman Sobol Shapiro. More »

Hagens Berman Alerts Investors Of Lead Plaintiff Deadline in Class Action Lawsuit Filed Against Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP)

Nov. 11, 2014

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors that a class action lawsuit has been filed against Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) (“Salix” or “the Company). The suit is pending in U.S. District Court for the Southern District of New York, and investors have until January 6, 2015 to move for lead plaintiff. More »

Hagens Berman Reminds Investors of the Upcoming Lead Plaintiff Deadline of December 23, 2014 in the Class Action Lawsuit Against iBio, Inc. (NYSE MKT: IBIO)

Nov. 11, 2014

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors that a class action lawsuit has been filed against iBio, Inc. (NYSE MKT: IBIO) (“iBio” or “the Company) The suit is pending in U.S. District Court for the District of Delaware and investors have until December 23, 2014 to move for lead plaintiff. More »

Hagens Berman Reminds Investors of the December 19, 2014 Lead Plaintiff Deadline in the Class Action Against Retrophin, Inc. (NASDAQ: RTRX)

Nov. 10, 2014

Hagens Berman Sobol Shapiro LLP, a top-tier investor-rights law firm, reminds investors that a securities fraud class action has been filed against Retrophin, Inc. (NASDAQ: RTRX) (“Retrophin” or “the Company”) for violations of the Securities Exchange Act of 1934. The Lead Plaintiff deadline in this case is December 19, 2014. More »